Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Tax Provisions (2018 - 2025)

Marimed (MRMD) has disclosed Tax Provisions for 7 consecutive years, with $2.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions rose 321.22% to $2.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.3 million, a 203.86% increase, with the full-year FY2024 number at $8.2 million, down 12.77% from a year prior.
  • Tax Provisions was $2.8 million for Q3 2025 at Marimed, up from $691000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $7.2 million in Q4 2021 to a low of -$2.0 million in Q4 2022.
  • A 5-year average of $2.4 million and a median of $2.5 million in 2022 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: surged 9214.56% in 2021, then tumbled 127.83% in 2022.
  • Marimed's Tax Provisions stood at $7.2 million in 2021, then crashed by 127.83% to -$2.0 million in 2022, then surged by 124.97% to $498000.0 in 2023, then soared by 901.81% to $5.0 million in 2024, then tumbled by 44.7% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Tax Provisions are $2.8 million (Q3 2025), $691000.0 (Q2 2025), and $2.8 million (Q1 2025).